Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors
Open Access
- 14 July 2011
- journal article
- research article
- Published by Hindawi Limited in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 6 (6), 462-472
- https://doi.org/10.1002/term.450
Abstract
Induced pluripotent stem cells (iPSCs) can provide an important source of cells for the next‐generation of cell therapies in regenerative medicine, in part due to their similarity to embryonic stem cells (ESCs). Patient‐specific iPSCs represent an opportunity for autologous cell therapies that are not restricted by immunological, ethical and technical obstacles. One of the technical hurdles that must be overcome before iPSCs can be clinically implemented is the scalable, reproducible production of iPSCs and their differentiated progeny. All of the iPSC lines established thus far have been generated and expanded with static tissue culture protocols, which are time‐consuming and suffer from batch‐to‐batch variability. Alternatively, stirred suspension bioreactors propose several benefits and their homogeneous culture environment facilitates the large‐scale expansion required for clinical studies at less cost. We have previously developed protocols for expanding murine and human ESCs as undifferentiated aggregates in stirred suspension bioreactors. The resulting cells were karyotypically normal, expressed pluripotency markers and could be differentiated into all three germ lineages, both in vitro and in vivo. In this study, we demonstrate that stirred suspension bioreactors yield 58‐fold expansion of undifferentiated pluripotent iPSCs over 4 days. In vitro differentiation into cartilage, bone and cardiomyocytes lineages, in addition to in vivo teratoma formation, further confirmed the existence of fully functional and undifferentiated pluripotent iPSC aggregates following long‐term passaging. Stirred suspension bioreactor culture represents an efficient process for the large‐scale expansion and maintenance of iPSCs, which is an important first step in their clinical application. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 32 references indexed in Scilit:
- Abrogation of E-Cadherin-Mediated Cellular Aggregation Allows Proliferation of Pluripotent Mouse Embryonic Stem Cells in Shake Flask BioreactorsPLOS ONE, 2010
- Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem CellsCell Stem Cell, 2010
- Reduced Differentiation Efficiency of Murine Embryonic Stem Cells in Stirred Suspension BioreactorsStem Cells and Development, 2010
- Identification of Five Developmental Processes during Chondrogenic Differentiation of Embryonic Stem CellsPLOS ONE, 2010
- Microenvironment Modulates Osteogenic Cell Lineage Commitment in Differentiated Embryonic Stem CellsPLOS ONE, 2010
- Technical Challenges in Using Human Induced Pluripotent Stem Cells to Model DiseaseCell Stem Cell, 2009
- Induced Pluripotent Stem Cell Lines Derived from Human Somatic CellsScience, 2007
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Rapid Generation of Stable Transgenic Embryonic Stem Cell Lines Using Modular LentivectorsThe International Journal of Cell Cloning, 2005